163 filings
Page 3 of 9
20-F
2021 FY
AMYT
Amryt Pharma Plc
Annual report (foreign)
29 Apr 22
3:13pm
424B3
AMYT
Amryt Pharma Plc
31 Mar 22
Prospectus supplement
8:44am
424B3
AMYT
Amryt Pharma Plc
31 Mar 22
Prospectus supplement
8:44am
6-K
AMYT
Amryt Pharma Plc
31 Mar 22
Results of General Meeting
8:41am
6-K
AMYT
Amryt Pharma Plc
16 Mar 22
Current report (foreign)
8:30am
424B3
AMYT
Amryt Pharma Plc
9 Mar 22
Prospectus supplement
9:26am
424B3
AMYT
Amryt Pharma Plc
9 Mar 22
Prospectus supplement
9:25am
6-K
AMYT
Amryt Pharma Plc
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
424B3
AMYT
Amryt Pharma Plc
28 Feb 22
Prospectus supplement
12:02pm
424B3
AMYT
Amryt Pharma Plc
28 Feb 22
Prospectus supplement
12:01pm
6-K
AMYT
Amryt Pharma Plc
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
AMYT
Amryt Pharma Plc
25 Feb 22
Current report (foreign)
4:05pm
SC 13G/A
AMYT
Amryt Pharma Plc
14 Feb 22
Amryt Pharma / UBS OCONNOR ownership change
10:34am
SC 13G
Rubric Capital Management LP
14 Feb 22
Amryt Pharma / Rubric Capital Management ownership change
8:59am
SC 13G/A
AMYT
Amryt Pharma Plc
11 Feb 22
Amryt Pharma / Stonepine Capital Management ownership change
2:27pm
SC 13G/A
Highbridge Capital Management LLC
11 Feb 22
Amryt Pharma / HIGHBRIDGE CAPITAL MANAGEMENT ownership change
8:18am
SC 13G/A
AMYT
Amryt Pharma Plc
11 Feb 22
Amryt Pharma / EdgePoint Investment ownership change
12:00am
424B3
AMYT
Amryt Pharma Plc
31 Jan 22
Prospectus supplement
7:35am
424B3
AMYT
Amryt Pharma Plc
31 Jan 22
Prospectus supplement
7:33am
6-K
AMYT
Amryt Pharma Plc
31 Jan 22
Current report (foreign)
7:32am